Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 20 → 21·12:19, 4 Sep 2025
Difference between revision 20 and revision 21 of Qingdao Saber Technology Pharmaceutical. 7 lines changed; the page grew by 144 bytes.
| Revision 20 — 16:29, 28 Aug 2025 DeadSpaceDot (talk) label community tally as self-reported 6,485 bytes +993 | Revision 21 — 12:19, 4 Sep 2025 DPP4_Dagmar (talk) attribute claim in-text 6,629 bytes +144 | ||
|---|---|---|---|
| 59 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 59 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 60 | 60 | ||
| + | 61 | == See also == | |
| + | 62 | * [[Certificate of analysis]] | |
| + | 63 | * [[Third-party testing]] | |
| + | 64 | * [[Area percent purity]] | |
| + | 65 | * [[Peptide content]] | |
| + | 66 | * [[Research use only]] | |
| + | 67 | ||
| 61 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} | 68 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} |
| 62 | [[Category:Peptide suppliers]] | 69 | [[Category:Peptide suppliers]] |